The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of su...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/27107
- Acceso en línea:
- https://doi.org/10.2174/1381612823666170918124419
https://repository.urosario.edu.co/handle/10336/27107
- Palabra clave:
- Pharmacodynamics
Neonate
Monitoring
Hemodynamics
Cerebral activity
Central nervous system
- Rights
- License
- Restringido (Acceso a grupos específicos)
id |
EDOCUR2_ea9f4c69d7f86bd256c6728584a950dd |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/27107 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
1e0fd7f0-251b-422b-a97e-5961db2b3861-1c9fafab1-fb47-4e52-93de-ff70fcf410d8-1df8f51ae-6ef0-4179-a77b-d75be3a821dc-1e2fc5044-be17-4fc6-9212-6261406e8bd2-121e3cc2b-385f-4821-a9ca-d9d7303f84ce-138de6b05-427b-4843-8821-5161b28c7324-12020-08-19T14:41:01Z2020-08-19T14:41:01Z2017Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of such drugs in neonates. Methods: We aim to provide an overview of the frequently used monitoring tools to assess drug effects on the hemodynamic status as well as the cerebral circulation, oxygenation and cerebral metabolism in neonates. Results: The use of blood pressure measurements, heart rate variability, functional echocardiography, nearinfrared spectroscopy and (amplitude-integrated) electroencephalography in neonates is discussed, as well as new parameters introduced by these tools. Based on the ‘brain circulation model’, the hemodynamic effects on the brain and their interplay are summarized. In this model, 3 processes (i.e. blood processes, vascular smooth muscle processes and tissue processes) and 3 mechanisms (i.e. autoregulation, blood flow metabolism coupling and cerebral oxygen balance) are distinguished, which all may be influenced by drug administration. Finally, propofol, sevoflurane, midazolam and inotropes are used as examples of which PD has been studied using the available hemodynamic and/or cerebral monitoring tools. Conclusion: The implementation of (non-)invasive monitoring tools to document hemodynamic and cerebral PD effects in neonates is of relevance both in a neonatal research and intensive clinical care setting. We highlight the need to integrate these tools in future PD research. Furthermore, besides short-term drug effects, long-term outcome of drug therapy in neonates also warrants further attention.application/pdfhttps://doi.org/10.2174/1381612823666170918124419ISSN: 1381-6128EISSN: 1873-4286https://repository.urosario.edu.co/handle/10336/27107engBentham Science Publishers5963No. 385955Current Pharmaceutical DesignVol. 23Current Pharmaceutical Design, ISSN: 1381-6128;EISSN: 1873-4286, Vol.23, No.38 (2017); pp. 5955-5963 https://www.eurekaselect.com/155663/articleRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecCurrent Pharmaceutical Designinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPharmacodynamicsNeonateMonitoringHemodynamicsCerebral activityCentral nervous systemThe use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonatesEl uso de monitorización hemodinámica y cerebral para estudiar la farmacodinámica en recién nacidosarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Smits, A.Thewissen, L.Dereymaeker, A.Dempsey, E.Caicedo, A.Naulaers, G.10336/27107oai:repository.urosario.edu.co:10336/271072021-06-03 00:50:05.795https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
dc.title.TranslatedTitle.spa.fl_str_mv |
El uso de monitorización hemodinámica y cerebral para estudiar la farmacodinámica en recién nacidos |
title |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
spellingShingle |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates Pharmacodynamics Neonate Monitoring Hemodynamics Cerebral activity Central nervous system |
title_short |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
title_full |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
title_fullStr |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
title_full_unstemmed |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
title_sort |
The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates |
dc.subject.keyword.spa.fl_str_mv |
Pharmacodynamics Neonate Monitoring Hemodynamics Cerebral activity Central nervous system |
topic |
Pharmacodynamics Neonate Monitoring Hemodynamics Cerebral activity Central nervous system |
description |
Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of such drugs in neonates. Methods: We aim to provide an overview of the frequently used monitoring tools to assess drug effects on the hemodynamic status as well as the cerebral circulation, oxygenation and cerebral metabolism in neonates. Results: The use of blood pressure measurements, heart rate variability, functional echocardiography, nearinfrared spectroscopy and (amplitude-integrated) electroencephalography in neonates is discussed, as well as new parameters introduced by these tools. Based on the ‘brain circulation model’, the hemodynamic effects on the brain and their interplay are summarized. In this model, 3 processes (i.e. blood processes, vascular smooth muscle processes and tissue processes) and 3 mechanisms (i.e. autoregulation, blood flow metabolism coupling and cerebral oxygen balance) are distinguished, which all may be influenced by drug administration. Finally, propofol, sevoflurane, midazolam and inotropes are used as examples of which PD has been studied using the available hemodynamic and/or cerebral monitoring tools. Conclusion: The implementation of (non-)invasive monitoring tools to document hemodynamic and cerebral PD effects in neonates is of relevance both in a neonatal research and intensive clinical care setting. We highlight the need to integrate these tools in future PD research. Furthermore, besides short-term drug effects, long-term outcome of drug therapy in neonates also warrants further attention. |
publishDate |
2017 |
dc.date.created.spa.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2020-08-19T14:41:01Z |
dc.date.available.none.fl_str_mv |
2020-08-19T14:41:01Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.2174/1381612823666170918124419 |
dc.identifier.issn.none.fl_str_mv |
ISSN: 1381-6128 EISSN: 1873-4286 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/27107 |
url |
https://doi.org/10.2174/1381612823666170918124419 https://repository.urosario.edu.co/handle/10336/27107 |
identifier_str_mv |
ISSN: 1381-6128 EISSN: 1873-4286 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
5963 |
dc.relation.citationIssue.none.fl_str_mv |
No. 38 |
dc.relation.citationStartPage.none.fl_str_mv |
5955 |
dc.relation.citationTitle.none.fl_str_mv |
Current Pharmaceutical Design |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 23 |
dc.relation.ispartof.spa.fl_str_mv |
Current Pharmaceutical Design, ISSN: 1381-6128;EISSN: 1873-4286, Vol.23, No.38 (2017); pp. 5955-5963 |
dc.relation.uri.spa.fl_str_mv |
https://www.eurekaselect.com/155663/article |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_16ec |
dc.rights.acceso.spa.fl_str_mv |
Restringido (Acceso a grupos específicos) |
rights_invalid_str_mv |
Restringido (Acceso a grupos específicos) http://purl.org/coar/access_right/c_16ec |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Bentham Science Publishers |
dc.source.spa.fl_str_mv |
Current Pharmaceutical Design |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167533280821248 |